FDA Inspection 1218571 — GXO Logistics Supply Chain Inc
The FDA completed an inspection of GXO Logistics Supply Chain Inc on Sep 18, 2023 in Dayton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Dayton, NJ (United States)